What began decades ago as the discovery of an antibody from mice that targets human cancer cells is now undergoing human trials in the US as the basis of a treatment for acute leukaemia.
Professor Andrew Boyd, who has seen his antibody discovery incorporated into a potential cancer treatment. Credit: QIMRThe antibody targets a protein called EphA3, which is found in about half of all acute leukaemias as well as many other human cancers including a significant proportion of malignant melanomas, brain tumours and lung cancers. The antibody, called KB004, has been shown to kill certain types of cancerous tumours grown from human samples. Continue reading Life’s work closer to saving lives→
Most mothers are aware that breast milk helps boost their baby’s immune levels, but up to now it has been thought that it is mainly because of the mother’s antibodies found in human milk.
